BARR GENERIC WARFARIN TO BE LAUNCHED IN SUMMER; DUPONT MERCK CONTINUES EFFORTS TO PASS STATE LAWS REQUIRING PHYSICIAN APPROVAL FOR NTI SUBSTITUTION